NCT06365840 2026-04-17
TMB-H
ImmuneOncia Therapeutics Inc.
Phase 2 Recruiting
Clinical Trials
3 trialsNCT05393713 2025-12-03
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study
Mayo Clinic
Phase 1 Terminated
NCT04414163 2025-06-18
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
ImmuneOncia Therapeutics Inc.
Phase 2 Active not recruiting